Recently, researchers from Imperial College London has developed a new device that uses innovative technology to increase outcomes for people having kidney disease and requiring dialysis. A project to develop such a technology has received a whopping a Â£1 million grant from the National Institute for Health Research. The grant will further take the endeavor through patient trials. The team of researchers have developed the procedure consisting of a synthetic tube, called a stent graft, forming the fistula for the process of dialysis. The procedure is the first of its kind for being minimally invasive. Furthermore, the prototype technology has been designed which enables inserting the stent graft in between artery and vein of a patient with greater accuracy and precision.
The device called an Electronic Percutaneous Anastomosis Technology for Haemodialysis or ePATH can help patients with kidney failure to avoid open surgery before dialysis treatment begins. This is possible as the system enables the creation of a vascular access site in a minimally invasive manner leading to less trauma among patients and faster recovery times.
After having a fully functioning ePATH prototype the team plans to move to the next phase of the product development and begin in-vivo trials by 2016. Clinical trials with patients are aimed to be carried out in early 2018.
The technology have further ramifications including improving coronary bypass procedures in patients with heart conditions and also helpful in opening up arteries that are blocked.
There are many reports in the market that tracks the recent industry development growth prospects, technological innovations and changing market dynamics of the medical dialysis. A recent report added by Prof Research Report titled â€œMarket Research Report on Global and Chinese Medical Dialysis Device Industry, 2009-2019â€ offers industry insights on the key drivers and restraints, market segmentation and forecast along with strategies of key market playersÂ to consolidate their presence in the market.